Abstract
This review updates the clinician on the pathogenesis, differential diagnosis and spectrum of disease in systemic sclerosis. The wide range of current therapeutic options and future targeted molecular therapies are also explored.
MeSH terms
-
Diagnosis, Differential
-
Global Health
-
Humans
-
Immunosuppressive Agents / therapeutic use*
-
Incidence
-
Scleroderma, Systemic* / diagnosis
-
Scleroderma, Systemic* / drug therapy
-
Scleroderma, Systemic* / epidemiology